No. 18-817 | |
Title: | Hikma Pharmaceuticals USA Inc., et al., Petitioners v. Vanda Pharmaceuticals Inc. |
Docketed: | December 27, 2018 |
Linked with 18A461 | |
Lower Ct: | United States Court of Appeals for the Federal Circuit |
Case Numbers: | (2016-2707, 2016-2708) |
Decision Date: | April 13, 2018 |
Rehearing Denied: | August 14, 2018 |
Date | Proceedings and Orders |
Oct 26 2018 | Application (18A461) to extend the time to file a petition for a writ of certiorari from November 12, 2018 to December 27, 2018, submitted to The Chief Justice. |
Main DocumentLower Court Orders/OpinionsProof of Service | |
Oct 31 2018 | Application (18A461) granted by The Chief Justice extending the time to file until December 27, 2018. |
Dec 27 2018 | Petition for a writ of certiorari filed. (Response due January 28, 2019) |
PetitionAppendixCertificate of Word CountProof of Service | |
Jan 22 2019 | Motion to extend the time to file a response from January 28, 2019 to February 12, 2019, submitted to The Clerk. |
Main Document | |
Jan 23 2019 | Motion to extend the time to file a response is granted and the time is extended to and including February 12, 2019. |
Jan 28 2019 | Brief amici curiae of Intellectual Property and Innovation Professors, Engine Advocacy, et al. filed. |
Main DocumentCertificate of Word CountProof of Service | |
Jan 28 2019 | Brief amici curiae of The Association for Accessible Medicines and Certain Individual Companies filed. |
Main DocumentCertificate of Word CountProof of Service | |
Feb 12 2019 | Brief of respondent Vanda Pharmaceuticals USA, Inc. in opposition filed. |
Main DocumentCertificate of Word CountProof of Service | |
Feb 26 2019 | Reply of petitioners Hikma Pharmaceuticals USA Inc., et al. filed. |
Main DocumentProof of ServiceOther | |
Feb 27 2019 | DISTRIBUTED for Conference of 3/15/2019. |
Mar 15 2019 | Letter of Hikma Pharmaceuticals USA Inc., et al. received. |
Main DocumentProof of Service | |
Mar 18 2019 | The Solicitor General is invited to file a brief in this case expressing the views of the United States. |
May 22 2019 | Amendment to Rule 29.6 Corporate Disclosure Statement filed with respect to brief in opposition of respondent Vanda Pharmaceuticals Inc. |
Main Document | |
Dec 06 2019 | Brief amicus curiae of United States filed. |
Proof of ServiceMain Document | |
Dec 20 2019 | Supplemental brief of petitioners Hikma Pharmaceuticals USA Inc., et al. filed. |
Main DocumentCertificate of Word CountProof of Service | |
Dec 23 2019 | DISTRIBUTED for Conference of 1/10/2020. |
Dec 23 2019 | Supplemental brief of respondent Vanda Pharmaceuticals USA, Inc. filed. (Distributed) |
Main DocumentCertificate of Word CountProof of Service | |
Dec 26 2019 | Letter of December 26, 2019 from counsel for petitioner received. (Distributed) |
Main Document | |
Jan 13 2020 | Petition DENIED. |
NAME | ADDRESS | PHONE |
Attorneys for Petitioners | ||
Charles Bennett Klein Counsel of Record | Winston & Strawn LLP 1700 K Street NW Washington, DC 20006 cklein@winston.com | 202-282-5977 |
Party name: Hikma Pharmaceuticals USA Inc., et al. | ||
Attorneys for Respondent | ||
Nicholas Groombridge Counsel of Record | Paul, Weiss, Rifkind, Wharton & Garrison LLP 1285 Avenue of the Americas New York, NY 10019 ngroombridge@paulweiss.com | 212-373-3000 |
Party name: Vanda Pharmaceuticals USA, Inc. | ||
Other | ||
Noel J. Francisco Counsel of Record | Solicitor General United States Department of Justice 950 Pennsylvania Avenue, NW Washington, DC 20530-0001 SupremeCtBriefs@USDOJ.gov | 202-514-2217 |
Party name: United States | ||
Douglas Clifford Hochstetler Counsel of Record | Kelley Drye & Warren LLLLP 333 West Wacker Drive, Suite 2600 Chicago, IL 60606-6402 DHochstetler@KelleyDrye.com | (312) 857-7070 |
Party name: THE ASSOCIATION FOR ACCESSIBLE MEDICINES AND CERTAIN INDIVIDUAL COMPANIES | ||
Phillip Robert Malone Counsel of Record | Juelsgaard Intellectual Property and Innovation Clinic Mills Legal Clinic at Stanford Law School 559 Nathan Abbott Way Stanford, CA 94305 pmalone@law.stanford.edu | 650-725-6369 |
Party name: Intellectual Property and Innovation Professors, Engine Advocacy, and The R Street Institute |